Results 241 to 250 of about 472,310 (340)

Resistance and resilience to Alzheimer's disease in Down syndrome. [PDF]

Alzheimers Dement
Boyle R, Koops EA, Ances B, Andrews EJ, Arenaza-Urquijo EM, Bejanin A, Brickman AM, Buckley RF, Clas GS, Costello E, Coughlan GT, Conley AC, Deng F, de Paula Faria D, Edwards N, Flores-Aguilar L, Fortea J, Ghazi Saidi L, Head E, Hom CL, Koenig K, Lao P, Lengyel I, Li YJ, Loi S, Loughrey D, McGlinchey E, Newhouse P, Pertierra L, Prokopiou PC, Qi Q, de Paula França Resende E, Russell J, Scanlon CE, Schneider C, Schultz SA, Seto M, Shaka S, Soldan A, Vaqué Alcázar L, Weng Y, Wilson JE, Zaman SH, Zsadányi SE, Hartley S.   +44 more
europepmc   +1 more source

In Situ Electrically Resettable Field‐Effect Transistor Biosensors for Continuous and Multiplexed Neurotransmitter Detection

Advanced Science, EarlyView.
The research team integrated a potentiometrically controlled pH electrode with carbon nanotube (CNT) field‐effect transistor (FET) biosensors on a single chip using compatible processes. By employing zonal modification and optimized pH‐sensitive probes, they achieved simultaneous quadruple‐target detection and tenfold reusability under physiological ...
Bo Xiao, Tingxian Li, Xianmao Cao, Yang Zhang, Jianping He, Mengmeng Xiao, Zhiyong Zhang   +6 more
wiley   +1 more source

Five-Year Longitudinal Brain Volume Change in Healthy Elders at Genetic Risk for Alzheimer\u27s Disease [PDF]

, 2017
Durgerian, Sally, Kelly, Dana A., Nielson, Kristy A., Rao, Stephen M., Reiter, Katherine, Seidenberg, Michael, Smith, J. Carson, Woodard, John L.   +7 more
core   +1 more source

Current and Emerging Pharmacological Treatment Options for Dementia

Behavioural Neurology, 2006
John M. Ringman, Jeffrey L. Cummings
doaj   +1 more source

Multi-Target Drug Design in Alzheimer's Disease Treatment: Emerging Technologies, Advantages, Challenges, and Limitations. [PDF]

Pharmacol Res Perspect
Hossain MS, Hussain MH.
europepmc   +1 more source

Symposium on neuropeptides: basic and clinical aspects. Neuropeptides and neurological disease. Alzheimer's disease.

, 1989
Shigenobu NAKAMURA
openalex   +2 more sources

Intestinal Clock Promotes Cognitive Memory Through Adenosine Signaling

Advanced Science, EarlyView.
The intestinal clock controls the expression of an adenosine enzyme that modulates systemic adenosine level and A1R signaling in the hippocampus, and in turn, cognitive function involving long‐term potentiation and BDNF‐dependent synaptic changes.
Min Chen, Fugui Zhang, Yifei Xiao, Xuejun Jiang, Zhiqian Yan, Jinyi Wang, Xiting Lv, Jialu Cui, Linna Ha, Hui Chen, Yongkang Dang, Zifei Qin, Jing Yang, Baojian Wu   +13 more
wiley   +1 more source

TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers [PDF]

, 2019
Benitez, Bruno A, Budde, John P, Cairns, Nigel J, Cruchaga, Carlos, Del-Aguila, Jorge L, Dube, Umber, Farias, Fabiana H.G., Fernandez, Maria Victoria, Harari, Oscar, Ibanez, Laura, Jiang, Shan, Li, Zeran, Mihindukulasuriya, Kathie A, Morris, John C, Perrin, Richard J   +14 more
core   +1 more source

Adaptive Machine Learning for Electronic Nose‐Based Forensic VOC Classification

Advanced Science, EarlyView.
A 32‐element electronic nose enhanced with machine learning demonstrates exceptional accuracy in differentiating between living and deceased individuals (98.1%), discriminating human and animal specimens (97.2%), and estimating postmortem intervals.
Ivan Shtepliuk, Kerstin Montelius, Jens Eriksson, Donatella Puglisi   +3 more
wiley   +1 more source